X
XBIT
Xbiotech
2.550
+0.040+1.59%Opening10:24 04/21 EDT
OPEN/PREV CLOSE2.550/2.510
TODAY RANGE2.500-2.560
VOL5.21K
MARKET CAP77.74M
52 WEEK RANGE2.090-3.610
AVG VOL (3M)38.78K
% TURNOVER0.02%
TURNOVER--
P/E (TTM)-1.7072
% RANGE2.40%
EPS(TTM)-1.4937
P/E(FORWARD)-1.4740
P/B0.5539
BVPS4.604
DIVIDEND--
P/S669.70
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP49.28M
SHARES OUTSTANDING30.49M
NEXT EARNINGS05/12-05/18
FREE FLOAT19.32M
LOT SIZE1
EX-DATE07/15/2021
News
Press Releases
Financial Reports
Profile
Barchart·03/13 15:16
XBiotech: Q4 Earnings Snapshot
TipRanks·12/09/2025 14:29
XBiotech CEO John Simard Announces Retirement
Reuters·12/09/2025 14:04
XBIOTECH INC - SUSHMA SHIVASWAMY APPOINTED INTERIM CEO OF XBIOTECH - SEC FILING
Reuters·12/09/2025 14:01
XBiotech Raises Interim CEO Sushma Shivaswamy’s Salary to $750,000
Benzinga·11/12/2025 22:24
XBiotech Q3 EPS $(0.20) Down From $(0.16) YoY
Barchart·11/12/2025 10:54
XBiotech: Q3 Earnings Snapshot
Simply Wall St·11/04/2025 10:10
We're Hopeful That XBiotech (NASDAQ:XBIT) Will Use Its Cash Wisely
TipRanks·10/27/2025 17:52
XBiotech’s New Trial: A Potential Game-Changer for Rheumatoid Arthritis Treatment?
Barchart·10/04/2025 10:54
XBiotech Signs New Executive Agreement with CEO
Same Industry
Name/Symbol
Change%
Price
Contact Us
Contact Number :+852 3852 8500Monday 7:00 AM - Saturday 9:00 AM (HKT)
Service Email :service@webull.hkOnline Support: Monday - Friday: 9:00 - 16:00; 22:30 - 5:00 (HKT)
Business Cooperation :marketinghk@webull.hkRisk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2026 Webull Securities Limited. All rights reserved.